Aortic root aneurysm formation is a cardinal feature of Marfan syndrome (MFS) and likely TGF-β driven via Smad (canonical) and ERK (non-canonical) signalling. The current study assesses human MFS vascular smooth muscle cell (SMC) phenotype, focusing on individual contributions by Smad and ERK, with Notch3 signalling identified as a novel compensatory mechanism against TGF-β-driven pathology. Although significant ERK activation and mixed contractile gene expression patterns were observed by traditional analysis, this did not directly correlate with the anatomic site of the aneurysm. Smooth muscle cell phenotypic changes were TGF-β-dependent and opposed by ERK in vitro, implicating the canonical Smad pathway. Bulk SMC RNA sequencing after ERK inhibition showed that ERK modulates cell proliferation, apoptosis, inflammation, and Notch signalling via Notch3 in MFS. Reversing Notch3 overexpression with siRNA demonstrated that Notch3 promotes several protective remodelling pathways, including increased SMC proliferation, decreased apoptosis and reduced matrix metalloproteinase activity, in vitro. In conclusion, in human MFS aortic SMCs: (a) ERK activation is enhanced but not specific to the site of aneurysm formation; (b) ERK opposes TGF-β-dependent negative effects on SMC phenotype; (c) multiple distinct SMC subtypes contribute to a 'mixed' contractile-synthetic phenotype in MFS aortic aneurysm; and (d) ERK drives Notch3 overexpression, a potential pathway for tissue remodelling in response to aneurysm formation. K E Y W O R D S aortic aneurysm, Marfan syndrome, smooth muscle cell phenotype 1 | INTRODUC TI ON Marfan syndrome (MFS) is an inheritable connective tissue disorder resulting from fibrillin-1 (Fbn1) mutations with an incidence of 1 in 5000 individuals. 1,2 Aortic root aneurysm formation and ensuing dissection accounts for early mortality if not surgically repaired prophylactically. 3 Transforming growth factor-beta (TGF-β) signalling is central to MFS aortic aneurysm pathogenesis. 4 Despite enhanced S U PP O RTI N G I N FO R M ATI O N Additional supporting information may be found online in the Supporting Information section. How to cite this article: Pedroza AJ, Koyano T, Trojan J, et al. Divergent effects of canonical and non-canonical TGF-β signalling on mixed contractile-synthetic smooth muscle cell phenotype in human Marfan syndrome aortic root aneurysms.
TGF-β signalling systemically, MFS patients classically develop focal aortic root aneurysms with preserved dimension of the adjacent ascending aorta. 5 We generally hypothesize that distinct embryonic origins of thoracic aortic segments 6 (second heart field, neural crest, or paraxial mesoderm) may govern variable aortic smooth muscle cell (SMC) response to enhanced TGF-β and explain this predisposition to aortic root dilatation, although hemodynamic and other biomechanical factors have been proposed as mediators of region-specific changes as well. 7 Paradoxically, TGF-β signalling seems to have a variable role depending on aortic developmental stage: critical for early normal aortic wall development, 8 while pathologic when enhanced during late aneurysm formation. 9 Multiple studies [10] [11] [12] and p38 mitogen-activated protein kinase (p38 MAPK)-dependent pathways. 13, 14 Holm et al 15 illustrated that selective ERK1/2 blockade reduces aneurysm development in a murine MFS model, whereas compound MFS Fbn1 C1039G/+ mutants with Smad4 knockout demonstrated worsened aneurysm severity, suggesting that these divergent TGF-β pathways may have opposing effects. It remains unclear how activation of these pathways results in aortic aneurysmal disease.
Moreover, the fidelity of this hypothesized mechanism in human disease has not been firmly established. Understanding the pathophysiology of the downstream TGF-β signalling pathways would provide a theoretical framework for the development of targeted therapeutics aimed at slowing or preventing aneurysm growth.
Smooth muscle cell dysfunction (modulation from contractile to the dedifferentiated synthetic phenotype) is known to contribute to aortic aneurysm development in a variety of hereditary aneurysm phenotypes. [16] [17] [18] Crosas-Molist et al 19 Intriguingly, we report that ERK drives Notch3 overexpression, a potential protective pathway for tissue remodelling in response to MFS aneurysm formation. Four Notch receptors (Notch 1-4) have been described in humans and represent large transmembrane proteins that bind ligands expressed on adjacent cells. 21 Because Notch plays a key role in neural crest migration and SMC differentiation during ascending aorta/aortic arch development, abnormal signalling may predispose to aneurysm formation. 22 Although Notch signalling has not been studied in MFS, Notch1 gene mutations have been reported in patients with bicuspid aortic valves (BAV) and BAV aortopathy. Notch 1-4 mRNA levels were significantly decreased in BAV aortic specimens compared to normal tricuspid aortic valve aortas. 23 Similarly, reduced Notch 1 and 3 gene expression levels were reported in human abdominal aortic aneurysm samples. 24 We hypothesize the Notch pathway incites productive tissue remodelling in response to MFS aneurysm formation and affords a provocative avenue for therapeutic intervention via forced Notch3 overexpression.
| MATERIAL S AND ME THODS

| Human studies
The Stanford Institutional Review Board (IRB) approved experiments involving human specimens. All patients included in this study gave informed consent for tissue banking and participation in human subject studies during elective cardiac surgery cases. Blanket research consent was obtained from surrogate decision-makers for all included organ donor controls by the referring organ procurement organization.
| Tissue handling
Fresh surgical specimens were collected within 30 minutes of excision, dissected to remove adventitial tissue, and snap-frozen in liquid nitrogen. For molecular assays, tissue samples were thawed and remaining adventitial and intimal layers removed. The tissue was snapfrozen prior to lysis for downstream analysis.
| Protein isolation and processing
Isolated medial aortic tissue was suspended in RIPA lysis buffer (MilliporeSigma, St. Louis, MO) supplemented with pan-protease and phosphatase inhibitor cocktail (MilliporeSigma) and disrupted with a rotor/stator homogenizer, snap-frozen and homogenized again.
Cultured SMCs monolayers were treated with Trypsin (TrypleE, Gibco), cells were pelleted in a microcentrifuge, washed in PBS and lysed with RIPA buffer. Lysates were allowed to dissociate on a rotator at 4°C for 60 minutes, then centrifuged to pellet insoluble tissue debris. The supernatant was collected and subjected to protein content quantification by BCA assay kit (ThermoFisher Scientific).
| Wes semi-quantitative protein immunoblotting
Protein lysates from tissue and in vitro cell culture lines were processed for use on Wes Simple Western assays according to manufacturer protocols (Protein Simple). Samples were mixed with Simple Western Sample Master Mix (80 mmol/L DTT, 2× sample buffer, 2× fluorescence standard) and denatured. The Simple Western kit plate was loaded with denatured samples, primary antibody, HRP-conjugated anti-rabbit antibody, luminol-peroxide substrate and wash buffers. The proprietary capillary-based separation system was utilized to automatically load, separate, immobilize and immunoprobe protein lysates for proteins of interest using HRPmediated chemiluminescence. The chemiluminescent signal was detected using the system's built-in CCD camera and analysed for signal intensity using accompanying Compass software. Band intensity was used to generate a traditional Western blot lane. Primary antibodies were titrated to determine optimal protein and primary antibody concentration. Antibodies for pERK1/2 (1:100 dilution, rabbit monoclonal, #4695), pSMAD2/3 (1:50 dilution, rabbit monoclonal, #8828), vinculin (1:150 dilution, rabbit polyclonal #4650) and
Notch3 (1:100 dilution, rabbit monoclonal #5276) were purchased from Cell Signaling Technology.
| RNA isolation and processing
Total RNA was extracted from frozen tissue using TRIzol (ThermoFisher Scientific). Cultured SMCs were trypsinized, pelleted in a microcentrifuge, washed in PBS and processed for RNA using the GeneJET RNA Purification Kit (ThermoFisher, Scientific). RNA was purified using the GeneJET RNA Cleanup and Concentration micro kit (ThermoFisher Scientific). RNA concentration was calculated using a NanoDrop spectrophotometer and quality determined by analysing the A 260/280 ratio for values > 1.9. 
| cDNA synthesis and quantitative RT-PCR
| Vascular SMC isolation and culture
Aortic tissue samples were placed into Waymouth's Medium for Aortic Biopsy supplemented with 3% Sodium Bicarbonate, 1.25% 200 mmol/L l-Glutamine (100×), 1% Antibiotic-Antimycotic (Anti-Anti) (100×), 1% 1 mol/L 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) (1×) and 1% Minimum Essential Medium Non-Essential Amino Acid Solution (MEM NEAA) (100×) (ThermoFisher Scientific) and transferred to a cell culture hood. Intima and adventitia layers were discarded, while the tunica media layer was placed into a culture dish containing 5 mL of aortic biopsy media with 0.1 mg/mL Collagenase Type I and 0.025 mg/mL Soybean Trypsin Inhibitor.
The aortic tissue was minced and the dish placed in an incubator overnight at 37°C and 5% CO 2 . Foetal bovine serum (Lonza) was added after incubation to arrest digestion. The contents were collected and centrifuged; the supernatant was removed and the pellet was released with 4 mL of SMC culture media that consisted of 
| SMC culture in vitro assays
Human aortic SMC lines were used for in vitro assays between pas- 
| Single-cell RNA sequencing
Human aortic root SMC lines were serum starved overnight then treated with differentiation media (1% FBS). The cells were then treated with Trypsin (TrypleE, Gibco) and resuspended into a single-cell suspension in PBS with 0.4% BSA. Single-cell capture and cDNA library synthesis were completed at the Stanford Functional Genomics Facility according to manufacturer specifications using a 10× Genomics microfluidic chip (10× Genomics, Pleasanton, CA).
Libraries were sequenced on an Illumina HiSeq 4000 instrument.
| mRNA sequencing and analysis
Total RNA pools from SMC lines treated with either (1) PD98059 or (2) vehicle control were prepared for mRNA sequencing using 
| Notch3 siRNA knockdown
Adherent SMCs of 60% confluence in 6 well plates were washed with PBS and transfected with (a) Notch3 siRNA (10 μmol/L) or (b) FAM-labelled scrambled control siRNA and Lipofectamine (ThermoFisher Scientific) for 4 hours in serum-free hSMC media.
Washed cells were imaged using fluorescence to confirm transfection success. Cells were cultured in hSMC media for 48 hours prior to further assays.
| MTT proliferation assay
Smooth muscle cells were seeded in a 96-well optical plate after siRNA transfection and given (a) standard or (b) serum-free hSMC media for 48 hours. The MTT assay (Promega) was performed according to the manufacturer's protocol and the absorbance read at 570 nm.
| Annexin V Apoptosis Assay (Fluorescence-Activated Cell Sorting)
Transfected SMCs were trypsinized and counted after 48 hours.
Smooth muscle cells (10 000) were incubated with fluorescein isothi- 
| Total elastin quantification assay
Total cell lysates after siRNA transection and 48 hours incubation were isolated from 200 000 cells using RIPA Buffer (MilliporeSigma).
Total bound elastin was quantified using the Fastin Elastin Kit (Biocolor; Carrickfergus, UK) using manufacturer protocols. A standard curve was generated with provided purified elastin for quantification of total sample elastin.
| Gelatin zymography
Conditioned media from siRNA-transfected SMCs incubated in hSMC media for 48 hours was collected and concentrated using Amicon Ultra-4 centrifugal filter tubes (Ultracel-30K) (MilliporeSigma). The pro and active forms of MMP-2 were evaluated with commercially available Gelatin Zymography Kit (Cosmobio) using 10 μL of concentrated supernatant according to manufacturer protocols. Band density was calculated using ImageJ.
| Statistical analysis
Statistics were calculated using R (https ://www.r-proje ct.org/). 
| RE SULTS
| ERK signalling is enhanced in both aneurysmal and normal calibre aortic specimens from MFS patients
Marfan syndrome patients with focal aortic root aneurysms Importantly, we did not find any statistically significant differences in the tested contractile genes with paired comparisons of MFS aneurysmal aortic root vs the same patient's non-dilated ascending aorta.
Synthetic genes related to ECM remodelling were also tested. Figure 2C ); there was no significant difference in MMP9 or TIMP1 expression. TIMP2 was significantly enhanced in MFS aortic root (4.2-fold, P = .04). There were no statistically significant differences between MFS aortic root and non-dilated ascending aorta for these genes.
Taken together, these results demonstrate that in MFS aortic root aneurysm specimens, both contractile and synthetic (ECM remodelling) gene pathways are activated suggesting a 'mixed' tissue phenotype.
| Smad and ERK signalling compete for regulation of MFS SMC contractile and ECM genes, in vitro
To 
| ERK affects critical gene pathways specific to MFS aortic root SMCs including Notch signalling
To better understand the role ERK signalling plays during aortic root root SMCs ( Figure 4C , complete list of pathways in Table S1 ). These and ligands as a driver for this significant response ( Figure 5D ). Figure 6A ).
| ERK activation increases Notch3 expression in MFS aortic aneurysms
F I G U R E 4
RNA-sequencing transcriptome-wide assessment with ERK inhibition. A, Volcano plots for whole-genome sequencing data depicting expression fold change with ERK inhibition relative to control and quantification of genes with significantly altered expression with ERK blockade at cut-off P < .05. n = 5. B, Workflow for identification of gene set with ERK responsive genes specificity to MFS aortic root. C, DAVID analysis of MFS Root-specific gene set (228 genes) stratified by biologic processes modulated with ERK blockade. RNA-sequencing data acquired from n = 5 donor and MFS aortic specimens
We next performed RT-PCR on primary aortic SMC cell lines treated with PD98059 or vehicle control for 24 hours (n = 5). Marfan syndrome aortic root SMCs demonstrated a significant reduction in Notch3 expression with ERK blockade, whereas Notch1 and 2 did not significantly change ( Figure 6B ). Therefore, these in vitro studies suggest that focal Notch3 overexpression in the aneurysmal MFS aortic root may be ERK-dependent.
| Notch3 enhances aortic root SMC proliferation, reduces apoptosis and modulates ECM turnover, in vitro
To better understand the role Notch3 may play during aneurysm formation, MFS aortic root SMC lines (n = 4 patients) were treated with a Notch3-specific siRNA or scrambled control (Scr), then tested for suggesting Notch3 naturally increases cell proliferation ( Figure 6E ).
Apoptosis was studied using a flow cytometry based assay for cell surface Annexin V ( Figure 6F ). In control conditions, no difference was detected in apoptosis (Annexin V staining) between Scr and Notch3 siRNA groups (11.9 ± 5.0% vs 12.2 ± 5.5%, P = .63). However, when Staurosporine treatment was used to induce apoptosis, Notch3 knockdown resulted in substantially higher Annexin V staining (63.3 ± 11.3% vs 40.8 ± 7.5%, P = .017). Finally, ECM turnover in response to Notch3 silencing was tested. Gelatin zymography from conditioned cell media demonstrated significantly more MMP2 activity (3.12 ± 1.7-fold, P = .014) with Notch3 knockdown (Figure 6G ).
Elastin and tropoelastin synthesis were quantified with a cell lysate-based assay and demonstrated modest but significant increase in ELN production with Notch3 silencing (24% increase, P = .013, Figure 6H ). These in vitro studies reveal that Notch3 likely reduces aortic root SMC contractile protein expression while enhancing cell proliferation, resisting apoptotic stimuli and decreasing MMP activity in MFS aortic root SMCs. While these changes suggest a largely protective role for Notch3 with regards to aneurysm biology, Notch3 may act as an inhibitor of ELN expression in vitro.
| D ISCUSS I ON
The pathophysiology of aneurysm development in MFS is a complex, multi-factorial process. TGF-β is central to this process; however, its effects appear highly dependent on developmental stage.
Further complicating matters, TGF-β signalling proceeds through multiple downstream pathways, including ERK. While ERK signalling has been implicated as a driver of aneurysm pathogenesis in the Fbn1 C1039G/+ MFS model, 15, 35 ERK activation was significantly enhanced with losartan and anti-TGF-β therapy and coincided with aneurysm prevention in the more aggressive Fbn1 mgR/mgR mouse model. 36 Furthermore, ERK inhibition exacerbated SMC pathology in an induced pluripotent stem cell-derived model of MFS by increasing apoptosis and reducing proliferation. 37 Importantly, whether ERK signalling drives aneurysm formation in the human disease has not been firmly established. Utilizing both human aortic specimens and primary cell culture lines, we systematically assessed ERK signalling in the context of SMC phenotype in MFS aortic root aneurysms.
The major findings of this study include the following: (a) ERK is uniformly activated in MFS aortic root and non-dilated ascending aorta;
(b) MFS aortic SMCs demonstrate increased heterogeneity characterized by both increased contractile and synthetic gene pathways in parallel; and (c) ERK does not drive these disturbances and may have beneficial effects including proliferation, dampening of TGF-βinduced changes and crosstalk with Notch3, which appears to play a protective role.
Our data demonstrate that ERK is robustly activated in both the MFS aneurysmal aortic root, as well as the normal calibre ascending aorta. Enhanced Smad2 activation in both aneurysmal and non-dilated aorta has been previously reported, 19 although Smad2 activation was more pronounced in the dilated aortic root using histopathologic techniques. Lineage studies have shown that vascular SMCs in the different aortic anatomic segments have distinct embryologic origins. 38 Recent reviews have suggested that the diversity of SMC origin may explain site-specific location of various diseases, including aneurysm formation. 39 Under this assumption, if enhanced ERK signalling contributes to MFS aneurysm formation, SMCs that originate from the aortic root (second heart field) must respond differently following ERK activation compared to SMC from the ascending aorta (neural crest). Our surgical specimens are intrinsically limited by analysis late in the disease process; therefore, the contribution of ERK to aneurysm development at earlier time-points remains unclear.
Phenotypic 'switching' of aortic constituent cells contributes to aneurysm formation in abdominal, 40, 41 descending thoracic 42 and aortic root aneurysms. 43 This study confirms the simultane- 
